Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Barberis

Showing results (11-20 of 169) with videos related to

Pageof 17
Sort By:
Journal of Clinical Pathology|November 23, 2016
Microsatellite instability evaluation by automated microfluidic electrophoresis: an updateFrancesco Pepe, Riccardo Smeraglio, Davide Vacirca, et al.
Journal of Clinical Pathology|May 26, 2018
Idylla assay and next generation sequencing: an integrated EGFR mutational testing algorithmCaterina De Luca, Alessandra G Rappa, Gianluca Gragnano, et al.
Ecancermedicalscience|May 20, 2015
Human papillomavirus in anal squamous cell carcinoma: an angel rather than a devil?Paola Simona Ravenda, Maria Giulia Zampino, Nicola Fazio, et al.
Immunotherapy|September 7, 2018
The immune profile of EGFR-mutated non-small-cell lung cancer at disease onset and progression after tyrosine kinase inhibitors therapyCaterina Fumagalli, Elena Guerini-Rocco, Davide Vacirca, et al.
Journal of Clinical Pathology|September 21, 2019
Next-generation sequencing-based BRCA testing on cytological specimens from ovarian cancer ascites reveals high concordance with tumour tissue analysisCaterina Fumagalli, Alessandra Rappa, Chiara Casadio, et al.
Frontiers in Oncology|June 17, 2022
Overcoming Resistance to Checkpoint Inhibitors: Natural Killer Cells in Non-Small Cell Lung CancerMaria Gemelli, Douglas M Noonan, Valentina Carlini, et al.
Molecular Cancer Therapeutics|December 11, 2007
The synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agentNicola Vannini, Girieca Lorusso, Rosaria Cammarota, et al.
Translational Lung Cancer Research|January 20, 2025
A rationale for the poor response to alectinib in a patient with adenocarcinoma of the lung harbouring a <i>STRN-ALK</i> fusion by artificial intelligence and molecular modelling: a case reportMassimo Barberis, Alessandra Rappa, Filippo de Marinis, et al.
Ecancermedicalscience|November 19, 2013
A rare case of lung metastasis from a malignant adenomyoepithelioma of the breast: histological features and therapeutic implicationsFausto Maffini, Giuseppe Renne, Rocco Olivadese, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2013
Results of the First Italian External Quality Assurance Scheme for somatic EGFR mutation testing in non-small-cell lung cancerNicola Normanno, Carmine Pinto, Gianluigi Taddei, et al.
Pageof 17

Showing results (11-20 of 169) with videos related to

Sort By:
Pageof 17
Journal of Clinical Pathology|November 23, 2016
Microsatellite instability evaluation by automated microfluidic electrophoresis: an updateFrancesco Pepe, Riccardo Smeraglio, Davide Vacirca, et al.
Journal of Clinical Pathology|May 26, 2018
Idylla assay and next generation sequencing: an integrated EGFR mutational testing algorithmCaterina De Luca, Alessandra G Rappa, Gianluca Gragnano, et al.
Ecancermedicalscience|May 20, 2015
Human papillomavirus in anal squamous cell carcinoma: an angel rather than a devil?Paola Simona Ravenda, Maria Giulia Zampino, Nicola Fazio, et al.
Immunotherapy|September 7, 2018
The immune profile of EGFR-mutated non-small-cell lung cancer at disease onset and progression after tyrosine kinase inhibitors therapyCaterina Fumagalli, Elena Guerini-Rocco, Davide Vacirca, et al.
Journal of Clinical Pathology|September 21, 2019
Next-generation sequencing-based BRCA testing on cytological specimens from ovarian cancer ascites reveals high concordance with tumour tissue analysisCaterina Fumagalli, Alessandra Rappa, Chiara Casadio, et al.
Frontiers in Oncology|June 17, 2022
Overcoming Resistance to Checkpoint Inhibitors: Natural Killer Cells in Non-Small Cell Lung CancerMaria Gemelli, Douglas M Noonan, Valentina Carlini, et al.
Molecular Cancer Therapeutics|December 11, 2007
The synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agentNicola Vannini, Girieca Lorusso, Rosaria Cammarota, et al.
Translational Lung Cancer Research|January 20, 2025
A rationale for the poor response to alectinib in a patient with adenocarcinoma of the lung harbouring a <i>STRN-ALK</i> fusion by artificial intelligence and molecular modelling: a case reportMassimo Barberis, Alessandra Rappa, Filippo de Marinis, et al.
Ecancermedicalscience|November 19, 2013
A rare case of lung metastasis from a malignant adenomyoepithelioma of the breast: histological features and therapeutic implicationsFausto Maffini, Giuseppe Renne, Rocco Olivadese, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2013
Results of the First Italian External Quality Assurance Scheme for somatic EGFR mutation testing in non-small-cell lung cancerNicola Normanno, Carmine Pinto, Gianluigi Taddei, et al.
Pageof 17